The need for preventive therapy in primary headaches
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista Headache Medicine (Online) |
Texto Completo: | https://headachemedicine.com.br/index.php/hm/article/view/78 |
Resumo: | Introduction: Primary headaches are common conditions. In Brazil, the prevalence of migraine is 15.2%, tension-type headache 13% and chronic daily headache (CDH) 6.9%. Although frequent disorders a proportion of patients are undertreated. Patients patterns of headache care can trend toward acute medication only and those in need of prevention may not receive it. Objective: To estimate the rates of preventive treatment in primary headache sufferers. Methods: A telephone interview containing questions about headache and socio-demographic characteristics was applied to 3,848 people from 27 States of Brazil, in its five geographical regions. We considered MIDAS > 10 points as a marker for the need of preventive treatment. Patients were asked if they were taking any medication on a daily basis or any treatment to prevent headaches from happening. Subjects were divided into: 1. Those who responded positively for the question regarding preventive treatment regardless of the treatment type. 2. Those who responded positively for the question, but only medications or treatments studied for migraine prevention, labeled as "Correct treatment" 3. Those who responded positively for the question, but only medications or treatments from the prevention consensus (Brazilian Headache Society), labeled as "Consensus treatment" Results: In total, 12.8% of primary headache sufferers had MIDAS higher than 10, meeting criteria for prophylactic treatment, but only 8.4% of them reported it, 3.9% were using a right preventive treatment. The percentage of patients in need for prevention was 24.7% in migraine, 15.6 % in probable migraine, 5 % for tension-type headache (TTH) and 4% for probable TTH. Only 2.6% of migraineurs, 7.5% of probable migraine patients, 4.3% of tension-type headache and 0% of probable TTH received proper preventive treatment Conclusion: Primary headaches are common, debilitating conditions but a substantial proportion of those who might need prevention do not receive it. Patient education, public health initiatives in order to deliver migraine and other primary headaches treatment for the general population should be considered not only in Brazil, but worldwide. |
id |
SBC_22bc44b7caaa5c82ac2fafa04d8f0fba |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/78 |
network_acronym_str |
SBC |
network_name_str |
Revista Headache Medicine (Online) |
repository_id_str |
|
spelling |
The need for preventive therapy in primary headachesA necessidade da terapia preventiva nas cefaleias primáriasEnxaqueca; MigrâneaCefaleia do tipo tensionalPrevençãoEpidemiologiaMigraineTension-type headachePreventionepidemiologyIntroduction: Primary headaches are common conditions. In Brazil, the prevalence of migraine is 15.2%, tension-type headache 13% and chronic daily headache (CDH) 6.9%. Although frequent disorders a proportion of patients are undertreated. Patients patterns of headache care can trend toward acute medication only and those in need of prevention may not receive it. Objective: To estimate the rates of preventive treatment in primary headache sufferers. Methods: A telephone interview containing questions about headache and socio-demographic characteristics was applied to 3,848 people from 27 States of Brazil, in its five geographical regions. We considered MIDAS > 10 points as a marker for the need of preventive treatment. Patients were asked if they were taking any medication on a daily basis or any treatment to prevent headaches from happening. Subjects were divided into: 1. Those who responded positively for the question regarding preventive treatment regardless of the treatment type. 2. Those who responded positively for the question, but only medications or treatments studied for migraine prevention, labeled as "Correct treatment" 3. Those who responded positively for the question, but only medications or treatments from the prevention consensus (Brazilian Headache Society), labeled as "Consensus treatment" Results: In total, 12.8% of primary headache sufferers had MIDAS higher than 10, meeting criteria for prophylactic treatment, but only 8.4% of them reported it, 3.9% were using a right preventive treatment. The percentage of patients in need for prevention was 24.7% in migraine, 15.6 % in probable migraine, 5 % for tension-type headache (TTH) and 4% for probable TTH. Only 2.6% of migraineurs, 7.5% of probable migraine patients, 4.3% of tension-type headache and 0% of probable TTH received proper preventive treatment Conclusion: Primary headaches are common, debilitating conditions but a substantial proportion of those who might need prevention do not receive it. Patient education, public health initiatives in order to deliver migraine and other primary headaches treatment for the general population should be considered not only in Brazil, but worldwide.Introdução: As cefaleias primárias são condições comuns. No Brasil, a prevalência da migrânea é 15,2%, da cefaleia do tipo tensional é 13% e da cefaleia crônica diária (CDH), 6,9%. Apesar de tratar-se de doenças frequentes, uma proporção dos pacientes é subtratada. Os padrões de manejo da cefaleia dos pacientes podem levar ao uso exclusivo de medicamentos para o tratamento agudo das crises, e aqueles que necessitam de prevenção podem não recebê-la. Objetivo: Estimar as taxas de tratamento preventivo entre os indivíduos portadores de cefaleias primárias. Métodos: Uma entrevista telefônica contendo questões sobre cefaleia e características sociodemográficas foi aplicado a 3.848 pessoas de 27 estados brasileiros, nas suas cinco regiões demográficas. Nos consideramos um escore na escala MIDAS>10 pontos como um marcador da necessidade de tratamento preventivo. Os pacientes foram questionados quanto ao uso de qualquer medicação em um padrão diário ou de qualquer tratamento para prevenir a ocorrência de crises de cefaleia. Os indivíduos foram divididos em: 1. Aqueles que responderam positivamente à questão sobre o tratamento preventivo, independentemente do tipo de tratamento. 2. Aqueles que responderam positivamente à questão, mas apenas com medicamentos ou tratamentos estudados no tratamento preventivo da migrânea, rotulados como "tratamento correto". 3. Aqueles que responderam positivamente à questão, mas apenas com medicamentos ou tratamentos citados no consenso sobre tratamento profilático da Sociedade Brasileira de Cefaleia, rotulados como "tratamento consenso". Resultados: No total, 12,8% dos indivíduos acometidos por cefaleias primárias apresentaram MIDAS maior que 10, preenchendo critérios para tratamento profilático, porém apenas 8,4% deles relataram-no, apenas 3,9% destes utilizando um tratamento correto. A porcentagem dos pacientes necessitando de prevenção foi 24,7% na migrânea, 15,6% na migrânea provável, 5% na cefaleia do tipo tensional e 4% na cefaleia do tipo tensional provável. Apenas 2,6% dos migranosos, 7,5% pacientes com migrânea provável, 4,3% daqueles com cefaleia do tipo tensional e 0% daqueles com cefaleia do tipo tensional provável receberam tratamento preventivo adequado. Conclusão: As cefaleias primárias são condições debilitantes e comuns, porém uma proporção substancial daqueles que poderiam necessitar de prevenção não a recebem. Educação dos pacientes e iniciativas de saúde pública voltadas a proporcionar à população tratamento para a migrânea e outras cefaleias primárias devem ser consideradas não apenas no Brasil, mas globalmente.Sociedade Brasileira de Cefaleia2011-06-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmlhttps://headachemedicine.com.br/index.php/hm/article/view/7810.48208/HeadacheMed.2011.10Headache Medicine; Vol. 2 No. 2 (2011); 46-49Headache Medicine; v. 2 n. 2 (2011); 46-492763-6178reponame:Revista Headache Medicine (Online)instname:Sociedade Brasileira de Cefaleiainstacron:SBCenghttps://headachemedicine.com.br/index.php/hm/article/view/78/87https://headachemedicine.com.br/index.php/hm/article/view/78/377Copyright (c) 2011 Headache Medicinehttps://creativecommons.org/licenses/by/4.0/deed.ptinfo:eu-repo/semantics/openAccessPeres, Mario Fernando Prieto Amado, Daniel Krempel Gonçalves, André Leite Ribeiro, Reinaldo Pagura, Jorge Roberto Queiroz, Luiz Paulo de 2022-04-19T16:28:33Zoai:ojs.pkp.sfu.ca:article/78Revistahttp://headachemedicine.com.brPRIhttps://headachemedicine.com.br/index.php/hm/oaimmvalenca@yahoo.com.br | support@headachemedicine.com.br2763-61782178-7468opendoar:2022-04-19T16:28:33Revista Headache Medicine (Online) - Sociedade Brasileira de Cefaleiafalse |
dc.title.none.fl_str_mv |
The need for preventive therapy in primary headaches A necessidade da terapia preventiva nas cefaleias primárias |
title |
The need for preventive therapy in primary headaches |
spellingShingle |
The need for preventive therapy in primary headaches Peres, Mario Fernando Prieto Enxaqueca; Migrânea Cefaleia do tipo tensional Prevenção Epidemiologia Migraine Tension-type headache Prevention epidemiology |
title_short |
The need for preventive therapy in primary headaches |
title_full |
The need for preventive therapy in primary headaches |
title_fullStr |
The need for preventive therapy in primary headaches |
title_full_unstemmed |
The need for preventive therapy in primary headaches |
title_sort |
The need for preventive therapy in primary headaches |
author |
Peres, Mario Fernando Prieto |
author_facet |
Peres, Mario Fernando Prieto Amado, Daniel Krempel Gonçalves, André Leite Ribeiro, Reinaldo Pagura, Jorge Roberto Queiroz, Luiz Paulo de |
author_role |
author |
author2 |
Amado, Daniel Krempel Gonçalves, André Leite Ribeiro, Reinaldo Pagura, Jorge Roberto Queiroz, Luiz Paulo de |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Peres, Mario Fernando Prieto Amado, Daniel Krempel Gonçalves, André Leite Ribeiro, Reinaldo Pagura, Jorge Roberto Queiroz, Luiz Paulo de |
dc.subject.por.fl_str_mv |
Enxaqueca; Migrânea Cefaleia do tipo tensional Prevenção Epidemiologia Migraine Tension-type headache Prevention epidemiology |
topic |
Enxaqueca; Migrânea Cefaleia do tipo tensional Prevenção Epidemiologia Migraine Tension-type headache Prevention epidemiology |
description |
Introduction: Primary headaches are common conditions. In Brazil, the prevalence of migraine is 15.2%, tension-type headache 13% and chronic daily headache (CDH) 6.9%. Although frequent disorders a proportion of patients are undertreated. Patients patterns of headache care can trend toward acute medication only and those in need of prevention may not receive it. Objective: To estimate the rates of preventive treatment in primary headache sufferers. Methods: A telephone interview containing questions about headache and socio-demographic characteristics was applied to 3,848 people from 27 States of Brazil, in its five geographical regions. We considered MIDAS > 10 points as a marker for the need of preventive treatment. Patients were asked if they were taking any medication on a daily basis or any treatment to prevent headaches from happening. Subjects were divided into: 1. Those who responded positively for the question regarding preventive treatment regardless of the treatment type. 2. Those who responded positively for the question, but only medications or treatments studied for migraine prevention, labeled as "Correct treatment" 3. Those who responded positively for the question, but only medications or treatments from the prevention consensus (Brazilian Headache Society), labeled as "Consensus treatment" Results: In total, 12.8% of primary headache sufferers had MIDAS higher than 10, meeting criteria for prophylactic treatment, but only 8.4% of them reported it, 3.9% were using a right preventive treatment. The percentage of patients in need for prevention was 24.7% in migraine, 15.6 % in probable migraine, 5 % for tension-type headache (TTH) and 4% for probable TTH. Only 2.6% of migraineurs, 7.5% of probable migraine patients, 4.3% of tension-type headache and 0% of probable TTH received proper preventive treatment Conclusion: Primary headaches are common, debilitating conditions but a substantial proportion of those who might need prevention do not receive it. Patient education, public health initiatives in order to deliver migraine and other primary headaches treatment for the general population should be considered not only in Brazil, but worldwide. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-06-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://headachemedicine.com.br/index.php/hm/article/view/78 10.48208/HeadacheMed.2011.10 |
url |
https://headachemedicine.com.br/index.php/hm/article/view/78 |
identifier_str_mv |
10.48208/HeadacheMed.2011.10 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://headachemedicine.com.br/index.php/hm/article/view/78/87 https://headachemedicine.com.br/index.php/hm/article/view/78/377 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2011 Headache Medicine https://creativecommons.org/licenses/by/4.0/deed.pt info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2011 Headache Medicine https://creativecommons.org/licenses/by/4.0/deed.pt |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Cefaleia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Cefaleia |
dc.source.none.fl_str_mv |
Headache Medicine; Vol. 2 No. 2 (2011); 46-49 Headache Medicine; v. 2 n. 2 (2011); 46-49 2763-6178 reponame:Revista Headache Medicine (Online) instname:Sociedade Brasileira de Cefaleia instacron:SBC |
instname_str |
Sociedade Brasileira de Cefaleia |
instacron_str |
SBC |
institution |
SBC |
reponame_str |
Revista Headache Medicine (Online) |
collection |
Revista Headache Medicine (Online) |
repository.name.fl_str_mv |
Revista Headache Medicine (Online) - Sociedade Brasileira de Cefaleia |
repository.mail.fl_str_mv |
mmvalenca@yahoo.com.br | support@headachemedicine.com.br |
_version_ |
1838629558820012032 |